Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Terbinafine HCl nail solutions with DDAIP HCl are more effective than current treatments for nail infections.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

The scaffold effectively prevents melanoma relapse and aids wound healing.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

High-dose iron therapy improves anemia without affecting IBD treatment.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

DFMO may help control hair growth and treat cancer.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Patients with chronic kidney disease on hemodialysis often have skin problems.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

A new fluorescent material can detect dextran sulfate sodium, turning green when present, useful for forensic and environmental monitoring.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.